,,ii  #aahth ,,congress  #ast ,session  
,s4 #baih  ,,in ,,the ,,senate ,,of     
,,the ,,united ,,states  ,june #bb1     
#bjbc,mr4 ,bennet 7for himself and ,mr4 
,lankford7 introduced the following     
bill2 which was read twice and referred 
to the ,committee on ,finance  ,a ,,bill
  ,to require the ,comptroller ,general 
of the ,united ,states to conduct a     
study and submit a report on            
price-related compensation and payment  
structures in the prescription drug     
supply chain4  #a4 ,short title ,this   
,act may be cited as the ,prescription  
,drug ,supply ,chain ,pricing           
,transparency ,act4  #b4 ,,gao study and
 report on price-related compensation   
and payment structures in the           
prescription drug supply chain ,section 
#ahfj;,d-#db of the ,social ,security   
,act 7#db ,u4,s4,c4 #aciew-#aeb7 is     
amended by adding at the end the        
following new subsection3  7e7 ,,gao    
study and report on price-,related      
compensation and payment structures in  

the prescription drug supply chain  7#a7
 ,study ,the ,comptroller ,general of   
the ,united ,states 7in this subsection 
referred to as the ,comptroller         
,general7 shall conduct a study on the  
use of compensation and payment         
structures related to a prescription    
drug's price within the retail          
prescription drug supply chain4 ,such   
study shall include an overview of the  
following3 7,a7 ,the type1 magnitude1   
other features 7such as the pricing     
benchmarks used71 and prevalence of     
compensation and payment structures     
related to a prescription drug's price1 
such as calculating fee amounts as a    
percentage of a prescription drug's     
price1 between intermediaries in the    
prescription drug supply chain1         
including-- 7i7 pharmacy benefit        
managers2  7ii7 part ,d plan sponsors2  
7iii7 drug wholesalers2  7iv7           
pharmacies2  7v7 manufacturers2  7vi7   
pharmacy services administrative        
organizations2  7vii7 brokers1 auditors1

 consultants1 and other entities that   
advise part ,d plan sponsors about      
pharmacy benefits or review part ,d plan
 sponsor contracts with pharmacy benefit
 managers2 and  7viii7 other service    
providers that contract with any of the 
entities described in clauses 7i7       
through 7vii71 including rebate         
aggregators 7or other entities that     
negotiate or process price concessions  
on behalf of pharmacy benefit managers  
or plan sponsors74  7,b7 ,the primary   
business models and compensation        
structures for each category of         
intermediary described in subparagraph  
7,a74  7,c7 ,variation in price-related 
compensation structures between         
affiliated entities 7such as entities   
with common ownership1 either full or   
partial1 and subsidiary relationships7  
and unaffiliated entities4  7,d7        
,potential conflicts of interest among  
contracting entities related to the use 
of prescription drug price-related      
compensation structures1 such as the    

potential for fees or other payments set
 as a percentage of a prescription      
drug's price to advantage the formulary 
selection1 distribution1 or purchasing  
of prescription drugs with higher       
prices4  7,e7 ,patterns and trends in   
price-based compensation structures over
 time and between different market      
segments1 such as under this part and   
the ,medicaid program under title ,,xix4
  7,f7 ,the factors driving the         
consideration and use of price-related  
compensation structures in the          
prescription drug supply chain4  7,g7   
,other issues determined to be relevant 
and appropriate by the ,comptroller     
,general4  7#b7 ,report ,not later than 
#b years after the date of enactment of 
this subsection1 the ,comptroller       
,general shall submit to ,congress a    
report containing the results of the    
study conducted under paragraph 7#a71   
together with recommendations for such  
legislation and administrative action as
 the ,comptroller ,general determines   

appropriate4  4